Skip Navigation

Rheumatology 2006 45(9):1100; doi:10.1093/rheumatology/kel055
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Matthews, C.
Right arrow Articles by Fitzgerald, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matthews, C.
Right arrow Articles by Fitzgerald, O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Clinical Vignette

C. Matthews and O. Fitzgerald

Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland

Correspondence to: C. Matthews. E-mail: cfmatthews@doctors.net

The first 10% of the full text of this article appears below.

The patient, a 69-yr-old man, had seropositive erosive rheumatoid arthritis (RA) diagnosed in 1977. He failed on the conventional disease-modifying agents of salazopyrin and methotrexate. Complications of Felty's syndrome (splenomegaly, neutropenia) and osteoporosis developed during his disease course. In 1997 he . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?